Exploring novel AEDs from drugs used for treatment of non-epileptic disorders
Authors:
- 10 March 2016
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Neurotherapeutics
- Vol. 16 (4) , 449-461
Abstract
(2016). Exploring novel AEDs from drugs used for treatment of non-epileptic disorders. Expert Review of Neurotherapeutics: Vol. 16, No. 4, pp. 449-461. doi: 10.1586/14737175.2016.1158101Keywords
This publication has 109 references indexed in Scilit:
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseasesNature Reviews Drug Discovery, 2012
- Altered inhibition in tuberous sclerosis and type IIb cortical dysplasiaAnnals of Neurology, 2011
- Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsyNeurobiology of Disease, 2010
- Celecoxib treatment restores pharmacosensitivity in a rat model of pharmacoresistant epilepsyBritish Journal of Pharmacology, 2010
- Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis ComplexNeurobiology of Disease, 2010
- The cortical innate immune response increases local neuronal excitability leading to seizuresBrain, 2009
- Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell deathNeuroscience Letters, 2008
- Amiloride delays the onset of pilocarpine-induced seizures in ratsBrain Research, 2008
- Intractable epilepsy: management and therapeutic alternativesThe Lancet Neurology, 2008
- Anomalous levels of Cl − transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatoryProceedings of the National Academy of Sciences, 2006